Traded Nov 3, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Traded Nov 3, 2025 · Filed Nov 5, 2025
The CEO of Visteon sold $33K of Visteon shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$33,006
Shares × reported transaction price
11 days after results of Oct 23, 2025, 108 days before results of Feb 19, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Filing box checked: sold under a Rule 10b5-1 plan
Only flagged when a footnote says so; never inferred
Traded Nov 3, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Sachin Lawande (CEO and President) sold ~$32K of Visteon
Automatic saleTraded Nov 3, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.